The bucco-linguo-masticatory syndrome as a side-effect of neuroleptics therapy.
D000328:Adult; D000368:Aged; D001925:Brain Damage, Chronic; D002610:Cheek / Q000503:physiopathology; D002746:Chlorpromazine / Q000009:adverse effects; D002749:Chlorprothixene / Q000009:adverse effects; D003006:Clopenthixol / Q000009:adverse effects; D005260:Female; D006220:Haloperidol / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008409:Mastication / Q000187:drug effects*; D008875:Middle Aged; D009069:Movement Disorders / Q000139:chemically induced*; D010300:Parkinson Disease / Q000188:drug therapy; D010546:Perphenazine / Q000009:adverse effects; D010640:Phenothiazines / Q000009:adverse effects; D012110:Reserpine / Q000009:adverse effects; D013881:Thioridazine / Q000009:adverse effects; D014059:Tongue / Q000503:physiopathology; D014149:Tranquilizing Agents / Q000009:adverse effects*
D010640:Phenothiazines; D014149:Tranquilizing Agents; D012110:Reserpine; D003006:Clopenthixol; D002749:Chlorprothixene; D010546:Perphenazine; D006220:Haloperidol; D013881:Thioridazine; D002746:Chlorpromazine